Orthocell Ltd
ASX:OCC

Watchlist Manager
Orthocell Ltd Logo
Orthocell Ltd
ASX:OCC
Watchlist
Price: 0.64 AUD -3.76% Market Closed
Market Cap: 153m AUD
Have any thoughts about
Orthocell Ltd?
Write Note

Orthocell Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Orthocell Ltd
Cost of Revenue Peer Comparison

Comparables:
MSB
CSL
CUV
TLX
PYC

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Orthocell Ltd
ASX:OCC
Cost of Revenue
-AU$1.6m
CAGR 3-Years
-38%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Mesoblast Ltd
ASX:MSB
Cost of Revenue
-$15.7m
CAGR 3-Years
22%
CAGR 5-Years
0%
CAGR 10-Years
N/A
CSL Ltd
ASX:CSL
Cost of Revenue
-$7.1B
CAGR 3-Years
-17%
CAGR 5-Years
-14%
CAGR 10-Years
-11%
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Cost of Revenue
AU$1.1m
CAGR 3-Years
-16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Telix Pharmaceuticals Ltd
ASX:TLX
Cost of Revenue
-AU$188.2m
CAGR 3-Years
-353%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
PYC Therapeutics Ltd
ASX:PYC
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Orthocell Ltd's Cost of Revenue?
Cost of Revenue
-1.6m AUD

Based on the financial report for Jun 30, 2024, Orthocell Ltd's Cost of Revenue amounts to -1.6m AUD.

What is Orthocell Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-17%

Over the last year, the Cost of Revenue growth was -59%. The average annual Cost of Revenue growth rates for Orthocell Ltd have been -38% over the past three years , -17% over the past five years .

Back to Top